read more

first_img August 15, 2012 — Mission Search Corp., a Tampa, Fla.-based healthcare search and staffing organization, announced it has joined with Sensus Healthcare to provide commissioning services to Sensus’ clientele.Sensus Healthcare is taking new aim by focusing on the design, manufacture and marketing of products and services that incorporate proprietary mobile X-ray technology for cost-effective, noninvasive treatment of non-melanoma skin cancers. The company’s SRT-100 meets the safety requirements set by the U.S. Food and Drug Administration (FDA), UL and ISO/CE mark certification.Based in Boca Raton, Fla., Sensus Healthcare employs best-practice standard operational procedures to ensure quality control, high-grade customer support, optimized success in field operations and product reliability.“We are pleased to partner with Sensus Healthcare to provide medical physics commissioning services for their superficial radiation therapy (SRT) systems and ultimately assisting Sensus as it brings non-melanoma skin cancer treatment to more patients in more settings,” said John Astrab, president and CEO of Mission Search Corp.Added Joe Sardano, president and CEO of Sensus Healthcare: “We are excited to be partnering with the Mission Search team. We both share the same values when it comes to customer service and satisfaction. We are very much looking forward to growing our business with another great partner as the need for SRT continues to evolve.”For more information: www.sensushealthcare.com, www.missionsearch.com FacebookTwitterLinkedInPrint分享 News | Proton Therapy | August 06, 2019 IBA Signs Contract to Install Proton Therapy Center in Kansas IBA (Ion Beam Applications S.A.) recently signed a contract and received the first payment for a Proteus One solution… read more Related Content News | August 15, 2012 Two Major Providers Announce Alliance to Provide Commissioning Services for Sensus SRT-100 News | Proton Therapy | August 08, 2019 MD Anderson to Expand Proton Therapy Center The University of Texas MD Anderson Cancer Center unveiled plans to expand its Proton Therapy Center during a… read more The top piece of content in July was a video interview explaining how Princess Margaret Cancer Center is using machine learning to create automated treatment plans. This was a hot topic at the American Association of Physicists in Medicine (AAPM) 2019 meeting in July.  News | Radiation Therapy | August 02, 2019 Varian Showcases Cancer Care Systems and Software at AAPM 2019 Varian showcased systems and software from its cancer care portfolio, including the Identify Guidance System, at the… read more News | Radiation Therapy | August 15, 2019 First Patient Enrolled in World’s Largest Brain Cancer Clinical Trial Henry Ford Cancer Institute is first-in-the-world to enroll a glioblastoma patient in the GBM AGILE Trial (Adaptive… read more News | Radiation Therapy | August 16, 2019 Drug Accelerates Blood System’s Recovery After Radiation, Chemotherapy A drug developed by UCLA physician-scientists and chemists speeds up the regeneration of mouse and human blood stem… read more News | Patient Positioning Radiation Therapy | August 15, 2019 Mevion and C-RAD Release Integration for Improved Proton Therapy Treatment Quality Mevion Medical Systems and C-RAD announced the integration between the C-RAD Catalyst PT and the Mevion S250i proton… read more The MD Anderson Proton Therapy Center expansion is expected to be completed in 2023. Rendering courtesy of Stantec. News | Radiation Oncology | July 31, 2019 Laura Dawson, M.D., FASTRO, Chosen as ASTRO President-elect The members of the American Society for Radiation Oncology (ASTRO) elected four new officers to ASTRO’s Board of… read more News | Brachytherapy Systems | August 14, 2019 Efficacy of Isoray’s Cesium Blu Showcased in Recent Studies August 14, 2019 — Isoray announced a trio of studies recently reported at scientific meetings and published in medica read more Feature | August 05, 2019 | Dave Fornell, Editor Most Popular Radiology and Radiotherapy Topics in July 2019 August 5, 2019 — Here is the list of the most popular content on the Imaging Technology New (ITN) magazine website fr read more Catalyst PT image courtesy of C-RAD Following radiation, the bone marrow shows nearly complete loss of blood cells in mice (left). Mice treated with the PTP-sigma inhibitor displayed rapid recovery of blood cells (purple, right). Credit: UCLA Broad Stem Cell Research Center/Nature Communications News | Patient Positioning Radiation Therapy | August 07, 2019 Qfix kVue One Proton Couch Top Validated by Mevion Medical Systems Qfix and Mevion Medical Systems announced that a special version of the kVue One Proton couch top is now both validated… read more last_img

Leave a Reply

Your email address will not be published. Required fields are marked *